Agonizing over engagement: SEA and the “death of environmentalism” debates

J Brown, J Dillard - Critical Perspectives on Accounting, 2013 - Elsevier
Social and environmental accounting (SEA) is currently going through a period of critical self-
analysis. Fundamental questions are being raised about how SEA should be defined, who …

[HTML][HTML] Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations

GJ Prud'Homme - Laboratory investigation, 2007 - Elsevier
Transforming growth factor β (TGF-β) is a highly pleiotropic cytokine that plays an important
role in wound healing, angiogenesis, immunoregulation and cancer. The cells of the …

[HTML][HTML] Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

LS Gunarathne, H Rajapaksha, N Shackel… - World journal of …, 2020 - ncbi.nlm.nih.gov
Portal hypertension and bleeding from gastroesophageal varices is the major cause of
morbidity and mortality in patients with cirrhosis. Portal hypertension is initiated by increased …

Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis

P Tandon, JG Abraldes, A Berzigotti… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Renin–angiotensin–aldosterone antagonists [ACE inhibitors
(ACEi), angiotensin receptor blockers (ARB), aldosterone antagonists (AA)] are potential …

Upregulation of angiotensin‐converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors

M Huang, X Li, Y Meng, B Xiao, Q Ma… - Clinical and …, 2010 - Wiley Online Library
The role of angiotensin‐converting enzyme (ACE) 2 is likely to balance the status of the
renin–angiotensin system (RAS) by degrading angiotensin (Ang) II and generating Ang‐(1 …

S2k-leitlinie nicht alkoholische Fettlebererkrankungen

E Roeb, HM Steffen, H Bantel… - Zeitschrift für …, 2015 - thieme-connect.com
Die nicht alkoholische Fettlebererkrankung ist eine Volkserkrankung und Ursache für 10–
20% der Zirrhosen und Formen des hepatozellulären Karzinoms (HCC) in unseren Breiten …

Update on new aspects of the renin-angiotensin system in hepatic fibrosis and portal hypertension: implications for novel therapeutic options

IG Rajapaksha, LS Gunarathne, PW Angus… - Journal of clinical …, 2021 - mdpi.com
There is considerable experimental evidence that the renin angiotensin system (RAS) plays
a central role in both hepatic fibrogenesis and portal hypertension. Angiotensin converting …

[HTML][HTML] Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension

KY Shim, YW Eom, MY Kim, SH Kang… - The Korean Journal of …, 2018 - ncbi.nlm.nih.gov
The renin-angiotensin system (RAS) is an important regulator of cirrhosis and portal
hypertension. As hepatic fibrosis progresses, levels of the RAS components angiotensin …

An update on non-peptide angiotensin receptor antagonists and related RAAS modulators

GK Aulakh, RK Sodhi, M Singh - Life sciences, 2007 - Elsevier
The renin–angiotensin–aldosterone-system (RAAS) is an important regulator of blood
pressure and fluid-electrolyte homeostasis. RAAS has been implicated in pathogenesis of …

The effect of angiotensin‐blocking agents on liver fibrosis in patients with hepatitis C

KE Corey, N Shah, J Misdraji, BK Abu Dayyeh… - Liver …, 2009 - Wiley Online Library
Background: Multiple studies implicate the renin–angiotensin system in hepatic
fibrogenesis. Few studies have examined the effects of angiotensin blockade on liver …